Filing Details

Accession Number:
0001140361-16-063350
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-04 16:16:51
Reporting Period:
2016-04-29
Filing Date:
2016-05-04
Accepted Time:
2016-05-04 16:16:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557533 Robert Jeffrey Ajer C/O Biomarin Pharmaceutical Inc.,
105 Digital Drive
Novato CA 94949
Evp, Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-04-29 415 $51.26 63,487 No 4 A Direct
Common Stock Disposition 2016-05-03 415 $86.03 63,072 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2015 to April 30, 2016.
  2. Transaction made pursuant to a Rule 10b5-1 trading plan executed on May 11, 2015.
  3. The price in column 4 is a weighted average price. The price actually received ranged from $85.32 to $86.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range